ABSTRACT
SARS-CoV-2 remains infectious for several hours on surfaces. It can be inactivated by UV-C irradiation but optimal conditions for rapid inactivation, especially on non-plastic surfaces remains unclear. A SARS-CoV-2 inoculum was irradiated with a UV-C LED (265 nm) or a UV-C mercury lamp (254 nm). Infectivity titers (TCID50/mL) and inactivation rates were then quantified on plastic, steel, tissue, paper and cardboard surfaces. We demonstrated that efficient SARS-CoV-2 inactivation (> 99.999% on plastic and steel, ≥ 99.8% on tissue, paper and cardboard) can be achieved by both a UV-C mercury lamp and a UV-C LED after 30 s of irradiations at 3 cm, corresponding to UV-C doses of 92.85 and 44.7 mJ/cm2, respectively. Inactivation on a plastic surface was more efficient with the mercury UV-C lamp (p < 0.005). The mercury UV-C lamp could be more relevant than the LED in high-risk settings, such as medical care or research laboratories.
ABSTRACT
The COVID-19 pandemic has generated great interest in ultraviolet (UV) disinfection, particularly for air disinfection. Although UV disinfection was discovered close to 90 years ago, only very recently has it reached the consumer market and achieved much acceptance from the public, starting in the 2000s. The current UV light source of choice has been almost exclusively a low-pressure mercury vapor discharge lamp. Today, however, with emerging deep-UV (DUV) chip-scale technologies, there has been a significant advancement, along with ever-increasing interest, in the development and deployment of disinfection systems that employ compact devices that emit in the deep-UV spectral band (200- 280 nm), including UV light-emitting diodes (LEDs) and cathodoluminescent (CL) chips. This perspective looks into competing UV technologies (including mercury lamps and excimer lamps as benchmarks) on their optical merits and demerits and discusses the emerging chip-scale technologies of DUV electroluminescent and cathodoluminescent devices, comparing them against the benchmarks and providing an overview of the challenges and prospects. The accelerating progress in chip-scale solutions for deep-UV light sources promises a bright future in UV disinfection.
ABSTRACT
The COVID-19 pandemic has raised interest in using devices that generate ultraviolet C (UVC) radiation as an alternative approach for reducing or eliminating microorganisms on surfaces. Studies investigating the efficacy of UVC radiation against pathogens use a wide range of laboratory methods and experimental conditions that can make cross-comparison of results and extrapolation of findings to real-world settings difficult. Here, we use three different UVC-generating sources - a broad-spectrum pulsed xenon light, a continuous light-emitting diode (LED), and a low-pressure mercury vapour lamp - to evaluate the impact of different experimental conditions on UVC efficacy against the coliphage MS2 on surfaces. We find that a nonlinear dose-response relationship exists for all three light sources, meaning that linear extrapolation of doses resulting in a 1-log10 (90%) reduction does not accurately predict the dose required for higher (e.g. 3-log10 or 99.9%) log10 reductions. In addition, our results show that the inoculum characteristics and underlying substrate play an important role in determining UVC efficacy. Variations in microscopic surface topography may shield MS2 from UVC radiation to different degrees, which impacts UVC device efficacy. These findings are important to consider in comparing results from different UVC studies and in estimating device performance in field conditions.